Finance

Beta
Roʻyxatlar
Aksiyalar sektorlari
Belgilar
Belgilar
Narxi
Oʻzgartirishlar
Dinamika (%)
Trend
Avvalgi yopilish narxi
Ochish
Yuqori
Past
Hajmi
Bozor kapitali
SIXB
Materials
SIXB
Materials
SIXB
-0,32%
1 100,57
-3,53
-0,32%
—1 104,101 103,921 108,751 097,16——
SIXC
Communications
SIXC
Communications
SIXC
+0,16%
605,15
+0,99
+0,16%
—604,16604,16610,19604,12——
SIXE
Energy
SIXE
Energy
SIXE
-0,22%
1 195,19
-2,62
-0,22%
—1 197,811 200,581 213,071 192,02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,03%
1 739,91
-0,50
-0,03%
—1 740,411 739,551 750,271 730,60——
SIXM
Financials
SIXM
Financials
SIXM
+0,65%
638,56
+4,12
+0,65%
—634,44633,13639,87633,01——
SIXR
Staples
SIXR
Staples
SIXR
-1,11%
831,57
-9,33
-1,11%
—840,90839,53841,73831,10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,82%
213,36
-1,77
-0,82%
—215,13215,13215,85213,24——
SIXT
Technology
SIXT
Technology
SIXT
+0,17%
3 234,18
+5,47
+0,17%
—3 228,713 225,623 235,433 198,95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,02%
935,65
-0,22
-0,02%
—935,87938,37942,00935,65——
SIXV
Health care
SIXV
Health care
SIXV
-0,54%
1 449,26
-7,86
-0,54%
—1 457,121 452,741 466,881 449,18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,72%
2 382,45
-17,39
-0,72%
—2 399,842 389,712 394,612 371,22——
ALNOV:EPA
Novacyt SA
0,36 €
-2,47%
(-0,0090) 1K
28-apr, 13:41:09 (GMT+2)  ·   EUR
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
ALNOV tikeri uchun statistika yaratilmoqda...
Ochish
0,36 €
Yuqori
0,36 €
Past
0,36 €
Bozor kapitali
25,88 mln
Oʻrtacha hajm
113,27 ming
Hajmi
39,74 ming
52 haftalik eng yuqori
0,74 €
52 haftalik eng past
0,36 €
Aksiya boʻyicha daromad
-0,50 €
Muomaladagi aksiyalar
72,59 mln
Xodimlar soni
234
Yangiliklar
Internetdagi manbalardan
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare. In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Novacyt SA haqida
CEODavid Allmond
Xodimlar soni234
Asos solingan3-iyl, 2006
Bosh ofislar-
Sektor-
Veb-saytnovacyt.com
Avvalgi hisobotlar
Loading Previous Earnings...
Daromad hisoboti
Daromad
Sof foyda
Barcha qiymatlar – GBP
sen, 2024
dek, 2024
mar, 2025
iyn, 2025
Daromad
-
-
4,90 mln
4,90 mln
Sotilgan mahsulotning tannarxi
-
-
1,64 mln
1,64 mln
Daromad narxi
-
-
1,64 mln
1,64 mln
Tadqiqot va ishlanmalarga xarajatlar
-
-
1,02 mln
1,02 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
-
-
5,51 mln
5,51 mln
Operatsion xarajatlar
-
-
6,43 mln
6,43 mln
Jami operatsion xarajatlar
-
-
8,08 mln
8,08 mln
Operatsion daromad
-
-
-3,18 mln
-3,18 mln
Boshqa nooperatsion daromad
-
-
-31,00 ming
-31,00 ming
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
-
-
-3,51 mln
-3,51 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
-
-
-3,12 mln
-3,12 mln
Daromad soligʻi boʻyicha xarajat
-
-
-133,50 ming
-133,50 ming
Amaldagi soliq stavkasi
-
-
3,80%
3,80%
Boshqa operatsion xarajatlar
-
-
-97,50 ming
-97,50 ming
Sof foyda
-
-
-3,17 mln
-3,17 mln
Sof foyda marjasi
-
-
-64,76%
-64,76%
Har bir aksiya foydasi
-
-
-
-
Foizlar va investitsiyalardan olingan daromadlar
-
-
177,00 ming
177,00 ming
Foizlarni toʻlash xarajatlari
-
-
-154,00 ming
-154,00 ming
Foizlarni toʻlash boʻyicha sof xarajatlar
-
-
23,00 ming
23,00 ming
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
-
-
-2,17 mln
-2,17 mln
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-147,50 ming
-147,50 ming
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish

Tahlil

Vazifalarim
Hali vazifa yaratmagansiz
Vazifalaringiz shu yerda chiqadi. Vazifalarni rejalashtiring va Google Finance xizmatidan foydalaning.
Andozalar
Kuzatuv roʻyxati brifingi
Kuzatuv roʻyxatining kunlik bozor oldidan tahlili
Kelgusi tushumlar
Hafta ichida kelgusi tushum hisobotlari
Anomal volatillik va hajm
Bugun erta ogohlantirish: volatillik va hajm
AI kontentda xatolar boʻlishi mumkin. Batafsil
YordamFikr-mulohazaMaxfiylikShartlarMajburiyatlardan voz kechish